Klinične študije za Miozitis v Illinois
7 študij za Miozitis išče udeležence na lokacijah v Illinois.
Mesta v Illinois
Uradno besedilo študije (angleško)
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
- Ann & Robert H. Lurie Children's Hospital of Chicago - Accepting Young Adult and Juvenile Patients, Chicago
- Northwestern Memorial Hospital - Accepting Adult Patients, Chicago
- The University of Chicago Medical Center - Accepting Adult and Juvenile Patients, Chicago
Vključevanje udeležencevFaza 2/3
Starost 6–75 · Vsi spoli · Posodobljeno 17. sep. 2026 · NCT06154252Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy
- University of Chicago, Department of Medicine: Rheumatology, Chicago
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 17. sep. 2026 · NCT07103746A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- The University of Chicago Medical Center, Chicago
Vključevanje udeležencevFaza 1
Starost 18–74 · Vsi spoli · Posodobljeno 10. sep. 2026 · NCT07085104A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
- Northwestern Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago
Vključevanje udeležencevFaza 1
Starost 18–70 · Vsi spoli · Posodobljeno 28. avg. 2026 · NCT06925542A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
- Nkarta Investigational Site, Chicago
Vključevanje udeležencevFaza 1/2
Starost 18–75 · Vsi spoli · Posodobljeno 7. avg. 2026 · NCT06733935AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
- Artiva Investigational Site Willowbrook, Willowbrook
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 31. jul. 2026 · NCT06991114A Study of AZD0120 in Autoimmune Diseases
- Research Site, Chicago
Vključevanje udeležencevFaza 1
Starost 18–75 · Vsi spoli · Posodobljeno 28. jul. 2026 · NCT07295847Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.